ReviewJournal of labelled compounds & radiopharmaceuticals2018

Preclinical optimization of antibody-based radiopharmaceuticals for cancer imaging and radionuclide therapy-Model, vector, and radionuclide selection.

Lukas M Carter et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.